Dörthe Holdhof

Also affiliated with University Medical Center Hamburg-Eppendorf, Kinderkrebs-Zentrum Hamburg, AstraZeneca (Germany)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “OLIG2 Is a Determinant for the Relapse of MYC -Amplified Medulloblastoma”.

OLIG2 Is a Determinant for the Relapse of MYC -Amplified Medulloblastoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0527

N/A

0DataRank · unranked

10 citations

Najiba Murad, Daniel Malawsky, Ran Tao, Samuel Rivero-Hinojosa, Dörthe Holdhof +8 more

Data from OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma

(2023)10.1158/1078-0432.c.6532710

N/A

0DataRank · unranked

0 citations

Najiba Murad, Daniel Malawsky, Ran Tao, Samuel Rivero-Hinojosa, Dörthe Holdhof +8 more